Morphine metabolism, transport and brain disposition

被引：110
作者：
De Gregori, Simona [1 ]
De Gregori, Manuela [2 ,3 ]
Ranzani, Guglielmina Nadia [3 ]
Allegri, Massimo [2 ,4 ]
Minella, Cristina [2 ]
Regazzi, Mario [1 ]
机构：
[1] Fdn IRCCS Policlin San Matteo, Clin Pharmacokinet Unit Transplantat & Autoimmune, I-7100 Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Anesthesia Intens Care & Pain Therapy Serv, Pavia, Italy
[3] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy
[4] Univ Pavia, Sect Anaesthesiol Resuscitat & Pain Therapy, Dept Surg Sci Resuscitat Rehabil & Organ Transpla, I-27100 Pavia, Italy
来源：
METABOLIC BRAIN DISEASE | 2012年 / 27卷 / 01期
关键词：
Blood-Brain-Barrier; Genetic variability; Morphine; Morphine-3-glucuronide; Morphine-6-glucuronide; Transport mechanisms; OPIOID RECEPTOR; P-GLYCOPROTEIN; BARRIER TRANSPORT; MORPHINE-6-GLUCURONIDE; GENE; RATS; GLUCURONIDATION; POLYMORPHISMS; MICE; MORPHINE-3-GLUCURONIDE;
D O I：
10.1007/s11011-011-9274-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The chemical structures of morphine and its metabolites are closely related to the clinical effects of drugs (analgesia and side-effects) and to their capability to cross the Blood Brain Barrier (BBB). Morphine-6-glucuronide (M6G) and Morphine-3-glucuronide (M3G) are both highly hydrophilic, but only M6G can penetrate the BBB; accordingly, M6G is considered a more attractive analgesic than the parent drug and the M3G. Several hypotheses have been made to explain these differences. In this review we will discuss recent advances in the field, considering brain disposition of M6G, UDP-glucoronosyltransferases (UGT) involved in morphine metabolism, UGT interindividual variability and transport proteins.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 31 条
  • [1] Allegri M, 2010, MINERVA ANESTESIOL, V76, P937
  • [2] Evidence for an active transport of morphine-6-β-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier
    Bourasset, F
    Cisternino, S
    Temsamani, J
    Scherrmann, JM
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 86 (06) : 1564 - 1567
  • [3] Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats-pharmacokinetic/pharmacodynamic modelling
    Bouw, MR
    Xie, RJ
    Tunblad, K
    Hammarlund-Udenaes, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (08) : 1796 - 1804
  • [4] Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
    Campa, D.
    Gioia, A.
    Tomei, A.
    Poli, P.
    Barale, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) : 559 - 566
  • [5] MORPHINE 6-GLUCURONIDE AND MORPHINE 3-GLUCURONIDE AS MOLECULAR CHAMELEONS WITH UNEXPECTED LIPOPHILICITY
    CARRUPT, PA
    TESTA, B
    BECHALANY, A
    ELTAYAR, N
    DESCAS, P
    PERRISSOUD, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (04) : 1272 - 1275
  • [6] MORPHINE-6-GLUCURONIDE HAS HIGH-AFFINITY FOR THE OPIOID RECEPTOR
    CHRISTENSEN, CB
    JORGENSEN, LN
    [J]. PHARMACOLOGY & TOXICOLOGY, 1987, 60 (01): : 75 - 76
  • [7] Coffman BL, 1998, DRUG METAB DISPOS, V26, P73
  • [8] THE ENANTIOSELECTIVE GLUCURONIDATION OF MORPHINE IN RATS AND HUMANS - EVIDENCE FOR THE INVOLVEMENT OF MORE THAN ONE UDP-GLUCURONOSYLTRANSFERASE ISOENZYME
    COUGHTRIE, MWH
    ASK, B
    RANE, A
    BURCHELL, B
    HUME, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (19) : 3273 - 3280
  • [9] Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
    Dagenais, C
    Rousselle, C
    Pollack, GM
    Scherrmann, JM
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (02) : 381 - 386
  • [10] The role of drug transporters at the blood-brain barrier
    de Boer, AG
    van der Sandt, ICJ
    Gaillard, PJ
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 : 629 - 656
1234